Havrix 360 Vaccine (Paediatric) Injection

Hepatitis A Virus (Inactivated) Vaccine
360 Units/Dose
SmithKline Beecham Biologicals SA
Pack size 1 Dose (0.5ml) Vial
Dispensing mode POM
Source BELGIUM
AgentGULF DRUG EST.
Retail Price 55.50 AED

Indications

Havrix 360 Vaccine (Paediatric) Injection is used for: Active immunization against Hepatitis A virus. Hepatitis A vaccine is used to prevent, hepatitis A

Adult Dose

Intramuscular Active immunisation against hepatitis A Adult: First dose: At selected date Second dose: 6 months after first dose

Child Dose

Intramuscular Active immunisation against hepatitis A Children of 1 year of age First dose: At selected date Second dose: 6 months after first dose Children 12 months to 15 years: The recommended dose is 0.5 ml First dose: At selected date Second dose: 6 months after first dose Children 16 years and above: The recommended dose is 1 ml First dose: At elected date Second dose: 6 months after first dose

Renal Dose

Administration

Hepatitis A vaccine should be given intramuscularly only.

Contra Indications

Hypersensitivity. Vaccines prepared in egg cultures are contraindicated in patients with hypersensitivity reactions to egg. Severe immunodeficiency. Malignant disease being treated with chemotherapy or radiotherapy and for at least 6 mth after stopping treatment. Patients with compromised immune system such as those on high-dose systemic corticosteroids, immunosuppressants or HIV positive.

Precautions

Alcohol or disinfectant used for cleaning the skin prior to inj should be allowed to evaporate completely before vaccination to prevent vaccine inactivation. The vaccine should be given to a pregnant woman only if clearly needed. Lactation: not established

Pregnancy-Lactation

Pregnancy Category: C Lactation: not established

Interactions

Reduced response to vaccination when used concurrently with immunosuppressants such as corticosteroids or antineoplastics.

Adverse Effects

Side effects of Hepatitis A Virus (Inactivated) Vaccine : >10% Injection site tenderness (3-56%), erythema (1-22%), warmth (1-17%), swelling (9-11%), Irritability (11-36%), Anorexia (1-19%), Drowsiness (15-17%), Headache (1-16%), Fever > 100.4 F (9-11%) 1-10% URI (1-10%), Otitis media (8%), Rhinorrhea (6%), Diarrhea (1-6%), Cough (1-5%), Rash (1-5%), Weakness/fatigue (4%), Vomiting (1-4%), Fever > 102 F (3%), Crying (2%) <1% Hematoma, Incr. CPK, Photophobia, Vertigo Potentially Fatal: Anaphylaxis.

Mechanism of Action

Hepatitis A antigen is prepared from formaldehyde-inactivated hepatitis A virus grown in human diploid cells. It is used for active immunisation against hepatitis A infection.

Note

Havrix 360 Vaccine (Paediatric) 360 Units/Dose Injection manufactured by SmithKline Beecham Biologicals SA. Its generic name is Hepatitis A Virus (Inactivated) Vaccine. Havrix 360 Vaccine (Paediatric) is availble in United Arab Emirates. Farmaco UAE drug index information on Havrix 360 Vaccine (Paediatric) Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Hepatitis A Virus (Inactivated) Vaccine :